Sort
172,184 grants matching “inflammation”
RP4: Harnessing autophagy to treat tuberculosis
$1,740,727Michael Shiloh · Ut Southwestern Medical Center · U19 · FY2020 · AI
Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial
$1,740,714Gaylan L Rockswold · Hennepin Healthcare Research Institute · U01 · FY2025 · NS
Development and Control of Pulmonary alveolar Stability
$1,740,662Samuel Hawgood · University Of California, San Francisco · P01 · FY2013 · HL
Inflammatory responses of vascular cells
$1,740,097Paul L Fox · Cleveland Clinic Lerner Com-Cwru · P01 · FY2013 · HL
Genetics, Pathophysiology, and Treatment of Dominant Autoinflammatory Diseases
$1,739,754Daniel Kastner · National Human Genome Research Institute · ZIA · FY2018 · HG
Genetics, Pathophysiology, and Treatment of Recessive Autoinflammatory Diseases
$1,739,754Daniel Kastner · National Human Genome Research Institute · ZIA · FY2018 · HG
Identification and Characterization of Signaling Pathways and Mediators Regulating Mast Cell-Related Disorders
$1,739,294Ana Olivera · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Studies of Central Nervous System Functional Anatomy
$1,739,164Miles A. Herkenham · National Institute Of Mental Health · ZIA · FY2017 · MH
Research Center for Pharmacology and Drug Toxicology
$1,738,501Jason D. Morrow · Vanderbilt University · P50 · FY2006 · GM
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier
$1,738,431Kari C. Nadeau · Stanford University · U01 · FY2022 · AI
Risk Factors for Stroke and Cognitive Decline in a Tri-Ethnic Region
$1,738,353Ralph Lewis Sacco · University Of Miami School Of Medicine · R01 · FY2015 · NS
Inflammation Pathways and COPD in the Development of Lung Cancer
$1,738,264Ann G Schwartz · Wayne State University · R01 · FY2012 · CA
Glucose, Insulin in Diabetic Vascular Disease
$1,738,004Catherine C Hedrick · University Of Virginia · P01 · FY2008 · HL
Development of EP2 Receptor Antagonist to Treat Alzheimer's Disease
$1,737,244Thota Ganesh · Emory University · U01 · FY2024 · AG
Microbiome, Metabolites, and Alcohol in HIV to Reduce CVD (META HIV CVD)
$1,737,037Matthew S Freiberg · Vanderbilt University Medical Center · P01 · FY2023 · AA
ETHER LIPIDS, EICOSANOIDS AND LUNG CELL PATHOPHYSIOLOGY
$1,737,023National Jewish Health · P01 · FY2004 · HL
Mechanisms of abdominal aortic aneurysm formation
$1,736,894Alan Daugherty · University Of Kentucky · P01 · FY2010 · HL
Pathophysiologies Involving Hemostasis-related Genes
$1,736,467University Of Notre Dame · P01 · FY2004 · HL
Ether Lipids, Elcosanoids, and Lung Cell Pathophysiology
$1,736,318Christina Carroll Leslie · National Jewish Health · P01 · FY2012 · HL
Genetic Factors to Oral Health Disparities in Appalachia
$1,735,919Mary L Marazita · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · DE
Energetics & Breast Cancer: Obesity, Inflammation, Insulin Resistance & Risk
$1,735,479Ruth E Patterson · University Of California, San Diego · U54 · FY2015 · CA
School Inner-City Asthma Intervention Study
$1,735,035Wanda Phipatanakul · Boston Children'S Hospital · U01 · FY2017 · AI
MECHANISMS OF REMODELING IN CHRONIC AIRWAY INFLAMMATION
$1,734,868University Of California San Francisco · P01 · FY2002 · HL
Environmentally Induced Alterations In Neuron And Glia Development and Aging
$1,734,410Gaylia Jean Harry · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
Development of a novel analgesic for mixed inflammatory and neuropathic pain states
$1,734,409Andrea Ghetti · Anabios Corporation · R44 · FY2021 · NS